Log in

897 Wai Yuen Tong Medicine Holdings Limited HKEX · Hong Kong

Wai Yuen Tong Medicine Holdings (897) news

Wai Yuen Tong Medicine Holdings Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 897, recorded under Hong Kong. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Wai Yuen Tong Medicine Holdings news

We have not published a story on Wai Yuen Tong Medicine Holdings yet. When there is news, it will appear here.

Questions about Wai Yuen Tong Medicine Holdings

What is the ticker symbol of Wai Yuen Tong Medicine Holdings?

Wai Yuen Tong Medicine Holdings Limited trades under the ticker 897 on HKEX.

Where is Wai Yuen Tong Medicine Holdings listed?

Wai Yuen Tong Medicine Holdings Limited is listed on HKEX.

Which country or territory is Wai Yuen Tong Medicine Holdings listed under?

Our directory records Wai Yuen Tong Medicine Holdings Limited under Hong Kong.

What does Wai Yuen Tong Medicine Holdings do?

Our directory classifies Wai Yuen Tong Medicine Holdings Limited as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline.

What is the ISIN of Wai Yuen Tong Medicine Holdings?

The ISIN recorded for Wai Yuen Tong Medicine Holdings Limited is BMG9421Y2332.

Does aibio.space cover Wai Yuen Tong Medicine Holdings?

aibio.space lists Wai Yuen Tong Medicine Holdings Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Wai Yuen Tong Medicine Holdings?

Companies in our directory listed in the same country and business area as Wai Yuen Tong Medicine Holdings: PuraPharm Corp., United Laboratories International Holdings, Pak Fah Yeow International, China Resources Pharmaceutical Group, CPBIO Holding Company, Lee's Pharmaceutical Holdings.

Investor discussion: Wai Yuen Tong Medicine Holdings

Members talk about Wai Yuen Tong Medicine Holdings (897). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Wai Yuen Tong Medicine Holdings, newest first. Each line links the filing it comes from.

  1. Mergers

    Transaction under the Listing Rules: MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE TARGET COMPANY. Source

  2. Mergers

    Transaction under the Listing Rules: DELAY IN DESPATCH OF CIRCULAR AND GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 14.41(A) OF THE LISTING RULES. Source

  3. Financings

    Share or debt issue: PROPOSALS FORTHE GRANT OF GENERAL MANDATES TO ISSUE AND TO REPURCHASE SHARES, RE-ELECTION OF THE RETIRING DIRECTORS, RE-APPOINTMENT OF AUDITOR, PROPOSED SHARE PREMIUM REDUCTION AND NOTICE OF ANNUAL GENERAL MEETING. Source

  4. Mergers

    Transaction under the Listing Rules: JOINT ANNOUNCEMENT MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE TARGET COMPANY. Source

  5. Financings

    Share or debt issue: PROPOSALS FOR THE GRANT OF GENERAL MANDATES TO ISSUE AND TO REPURCHASE SHARES, RE-ELECTION OF THE RETIRING DIRECTORS, PROPOSED AMENDMENTS TO SHARE OPTION SCHEME AND NOTICE OF ANNUAL GENERAL MEETING. Source

Press releases

Headlines of Wai Yuen Tong Medicine Holdings's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    DOCUMENTS ON DISPLAY

  2. HKEXnews

    LETTER TO NON-REGISTERED SHAREHOLDER(S) AND REQUEST FORM

  3. HKEXnews

    LETTER TO EXISTING REGISTERED SHAREHOLDER(S) AND CHANGE REQUEST FORM

  4. HKEXnews

    MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE TARGET COMPANY

  5. HKEXnews

    POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 19 AUGUST 2026

  6. HKEXnews

    DELAY IN DESPATCH OF CIRCULAR AND GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 14.41(A) OF THE LISTING RULES

  7. HKEXnews

    LETTER TO NON-REGISTERED HOLDER(S) AND REQUEST FORM

  8. HKEXnews

    NOTICE OF ANNUAL GENERAL MEETING

  9. HKEXnews

    PROPOSALS FORTHE GRANT OF GENERAL MANDATES TO ISSUE AND TO REPURCHASE SHARES, RE-ELECTION OF THE RETIRING DIRECTORS, RE-APPOINTMENT OF AUDITOR, PROPOSED SHARE PREMIUM REDUCTION AND NOTICE OF ANNUAL GENERAL MEETING

  10. HKEXnews

    JOINT ANNOUNCEMENT MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE TARGET COMPANY

  11. HKEXnews

    PROPOSED SHARE PREMIUM REDUCTION

  12. HKEXnews

    ANNOUNCEMENT OF FINAL RESULTS FOR THE YEAR ENDED 31 MARCH 2026

  13. HKEXnews

    TERMS OF REFERENCE OF NOMINATION COMMITTEE

  14. HKEXnews

    LETTER TO NEW REGISTERED SHAREHOLDER(S) AND REPLY FORM - ELECTION OF MEANS OF RECEIPT AND LANGUAGE OF CORPORATE COMMUNICATIONS

  15. HKEXnews

    ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025

  16. HKEXnews

    PROFIT WARNING

  17. HKEXnews

    POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 19 AUGUST 2025

  18. HKEXnews

    PROPOSALS FOR THE GRANT OF GENERAL MANDATES TO ISSUE AND TO REPURCHASE SHARES, RE-ELECTION OF THE RETIRING DIRECTORS, PROPOSED AMENDMENTS TO SHARE OPTION SCHEME AND NOTICE OF ANNUAL GENERAL MEETING

  19. HKEXnews

    ANNOUNCEMENT OF FINAL RESULTS FOR THE YEAR ENDED 31 MARCH 2025

  20. HKEXnews

    Terms of Reference of Audit Committee

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:897 on TradingView.

Listing details

Wai Yuen Tong Medicine Holdings Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 897, recorded under Hong Kong. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Wai Yuen Tong Medicine Holdings Limited
Ticker
897
Listing
HKEX
Country or territory
Hong Kong
Business scope
Biopharma / pharmaceutical profile checked
ISIN
BMG9421Y2332
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.